US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Birth Control

1,144.13

-40.8384-3.45%

Number of Gainers:1

Number of Losers:4

Number of Flat:1

PE:- -

High:1,183.57

Open:1,183.57

Low:1,142.78

Close:1,184.98

Loading ...

MannKind Showcases Efficacy, Safety, and Mealtime Control Data from Recent Pediatric and Adult Studies of Afrezza® at the ATTD Conference, March 19-22

Down -9.23% in 4 Weeks, Here's Why Veru (VERU) Looks Ripe for a Turnaround

Teva price target lowered to $20 from $23 at BofA

Analysts Offer Insights on Healthcare Companies: Zymeworks (ZYME), Teva Pharmaceutical (TEVA) and Incyte (INCY)

BRIEF-Teva Launches Spring Summer 2025 Collection Designed For Playground Earth

Teva Launches Spring Summer 2025 Collection; Designed for Playground Earth

THOMSON REUTERS

Is Teva Pharmaceuticals Industries Limited (TEVA) the Best Weight Loss Drug Stock to Buy According to Analysts?

Sanofi's Positive Duvakitug Data Raises Market Questions for Teva Pharmaceutical Industries (NYSE:TEVA)

Simply Wall St.

Is Teva Pharmaceutical Industries Limited (TEVA) the Best Low Price Pharma Stock to Invest In Right Now?

2025 Community Routes: Access to Mental Health Care Grants Awarded to Clinics in Alabama, Mississippi, and Texas, Funded by Teva Pharmaceuticals

THOMSON REUTERS

2025 Community Routes: Access to Mental Health Care Grants Awarded to Clinics in Alabama, Mississippi, and Texas, Funded by Teva Pharmaceuticals

Analysts Are Bullish on These Healthcare Stocks: Sarepta Therapeutics (SRPT), MannKind (MNKD)

MannKind Corporation Reports Strong 2024 Financial Growth

BRIEF-MannKind Files For Mixed Shelf - SEC Filing

MannKind files automatic mixed securities shelf

MannKind Corp Files for Mixed Shelf - SEC Filing

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.tigerhkgo.com/stock/BK4584/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4584"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4584\",,,,,undefined,":{"symbol":"BK4584","market":"US","secType":"PLATE","nameCN":"Birth Control","latestPrice":1144.1382,"timestamp":1741615401239,"preClose":1184.9766,"halted":0,"volume":1334185,"delay":0,"changeRate":-0.034463,"change":-40.838379,"pbRate":3.546252,"amount":14476305.948616,"amplitude":0.034421,"prevYearClose":1682.2216,"fiveDayClose":1231.4114,"twentyDayClose":1299.5316,"turnoverRate":0.000813,"marketCap":18640409540,"floatMarketCap":18516327298,"peRate":-10.596895},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4584\",,,,,undefined,":{"symbol":"BK4584","high":1183.5695,"amplitude":0.034421,"preClose":1184.9766,"low":1142.7819,"pbRate":"3.546252","latestPrice":1144.1311,"volume":1330785,"delay":0,"open":1183.5695,"prevYearClose":1682.2216,"prevWeekClose":1184.9766,"prevMonthClose":1268.0868,"prevQuarterClose":1682.2216,"fiveDayClose":1231.4114,"twentyDayClose":1299.5316,"sixtyDayClose":1372.695,"secType":"PLATE","market":"US","turnoverRate":0.00081,"peRate":-10.596895,"marketCap":18640294852,"floatMarketCap":18516213634,"timestamp":1741615400574,"nameCN":"Birth Control"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4584\",,,,undefined,":{"bkCode":"BK4584","up":1,"down":4,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4584\",pageSize:16,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2518224329","title":"MannKind Showcases Efficacy, Safety, and Mealtime Control Data from Recent Pediatric and Adult Studies of Afrezza® at the ATTD Conference, March 19-22","url":"https://stock-news.laohu8.com/highlight/detail?id=2518224329","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518224329?lang=en_us&edition=fundamental","pubTime":"2025-03-10 18:05","pubTimestamp":1741601100,"startTime":"0","endTime":"0","summary":"Five presentations affirm positive outcomes utilizing inhaled insulinAn sNDA filing for Afrezza in pediatric population anticipated in 2025 DANBURY, Conn. and WESTLAKE VILLAGE, Calif., March  10, 2025   -- MannKind Corporation , a company focused on the development and commercialization of inhaled therapeutic products and delivery devices for patients with endocrine and orphan lung diseases, will showcase data from recent studies of inhaled insulin across five presentations at the 18th International Conference on Advanced Technologies and Treatments for Diabetes to be held March 19-22 in Amsterdam. “Data from both the INHALE-1 pediatric and INHALE-3 adult studies continue to drive groundbreaking conversations around inhaled insulin,” said Dr. Kevin Kaiserman, Senior Vice President, Therapeutic Area Head, Endocrine Diseases for MannKind Corporation. \"Afrezza continues to be an important treatment option for adults living with diabetes, including those utilizing MDI and AID, and we look ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/10/3039535/29517/en/MannKind-Showcases-Efficacy-Safety-and-Mealtime-Control-Data-from-Recent-Pediatric-and-Adult-Studies-of-Afrezza-at-the-ATTD-Conference-March-19-22.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CET","BK4139","MNKD","RCT","BK4584","RAA"],"gpt_icon":0},{"id":"2517198860","title":"Down -9.23% in 4 Weeks, Here's Why Veru (VERU) Looks Ripe for a Turnaround","url":"https://stock-news.laohu8.com/highlight/detail?id=2517198860","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517198860?lang=en_us&edition=fundamental","pubTime":"2025-03-06 22:35","pubTimestamp":1741271706,"startTime":"0","endTime":"0","summary":"A downtrend has been apparent in Veru Inc.  lately with too much selling pressure. The stock has declined 9.2% over the past four weeks. However, given the fact that it is now in oversold territory and Wall Street analysts are majorly in agreement about the company's ability to report better earnings than they predicted earlier, the stock could be due for a turnaround.We use Relative Strength Index , one of the most commonly used technical indicators, for spotting whether a stock is oversold. This is a momentum oscillator that measures the speed and change of price movements.RSI oscillates between zero and 100. Usually, a stock is considered oversold when its RSI reading falls below 30.Technically, every stock oscillates between being overbought and oversold irrespective of the quality of their fundamentals. And the beauty of RSI is that it helps you quickly and easily check if a stock's price is reaching a point of reversal.The RSI reading of 25.85 for VERU is an indication that the h","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/down-9-23-4-weeks-143506752.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["RSI","VERU","BK4584","BK4557","BK4150","BK4183"],"gpt_icon":0},{"id":"2517165687","title":"Teva price target lowered to $20 from $23 at BofA","url":"https://stock-news.laohu8.com/highlight/detail?id=2517165687","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517165687?lang=en_us&edition=fundamental","pubTime":"2025-03-06 22:22","pubTimestamp":1741270922,"startTime":"0","endTime":"0","summary":"BofA lowered the firm’s price target on Teva (TEVA) to $20 from $23 and keeps a Buy rating on the shares. The firm revised lower its FY26 and FY27 ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/teva-price-target-lowered-to-20-from-23-at-bofa?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/teva-price-target-lowered-to-20-from-23-at-bofa?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4557","BK4588","BK4566","BK4007","TEVA","BK4596","BK4584","BK4585","BK4559"],"gpt_icon":0},{"id":"2517153665","title":"Analysts Offer Insights on Healthcare Companies: Zymeworks (ZYME), Teva Pharmaceutical (TEVA) and Incyte (INCY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2517153665","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517153665?lang=en_us&edition=fundamental","pubTime":"2025-03-06 19:10","pubTimestamp":1741259412,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Zymeworks (ZYME – Research Report), Teva Pharmaceu...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-zymeworks-zyme-teva-pharmaceutical-teva-and-incyte-incy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-zymeworks-zyme-teva-pharmaceutical-teva-and-incyte-incy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","ZYME","BK4550","BK4566","HCSG","BK4557","INCY","TEVA","BK4532","BK4584","BK4559","BK4137","BK4588","BK4596","BK4139","BK4007"],"gpt_icon":0},{"id":"2516674647","title":"BRIEF-Teva Launches Spring Summer 2025 Collection Designed For Playground Earth","url":"https://stock-news.laohu8.com/highlight/detail?id=2516674647","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516674647?lang=en_us&edition=fundamental","pubTime":"2025-03-04 22:12","pubTimestamp":1741097556,"startTime":"0","endTime":"0","summary":"BRIEF-Teva Launches Spring Summer 2025 Collection Designed For Playground EarthMarch 4 (Reuters) - Deckers Outdoor Corp DECK.N:TEVA LAUNCHES SPRING SUMMER 2025 COLLECTION; DESIGNED FOR PLAYGROUND EARTHSource text: ID:nBw6JdgLzaFurther company coverage: DECK.N (Reuters.Briefs@thomsonreuters.com)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250304:nTUAMZZTT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","BK4588","BK4557","LU0266013472.USD","TEVA","BK4007","BK4567","DECK","BK4585","BK4146","BK4559","BK4596","BK4584"],"gpt_icon":0},{"id":"2516671229","title":"Teva Launches Spring Summer 2025 Collection; Designed for Playground Earth","url":"https://stock-news.laohu8.com/highlight/detail?id=2516671229","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516671229?lang=en_us&edition=fundamental","pubTime":"2025-03-04 22:00","pubTimestamp":1741096803,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250304:nTUAMZZTT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4559","TEVA","BK4146","BK4588","BK4566","BK4584","BK4557","LU0266013472.USD","BK4567","BK4007","DECK","BK4585","BK4596"],"gpt_icon":0},{"id":"2516566388","title":"Is Teva Pharmaceuticals Industries Limited (TEVA) the Best Weight Loss Drug Stock to Buy According to Analysts?","url":"https://stock-news.laohu8.com/highlight/detail?id=2516566388","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516566388?lang=en_us&edition=fundamental","pubTime":"2025-03-02 03:52","pubTimestamp":1740858743,"startTime":"0","endTime":"0","summary":"We recently published a list of 10 Best Weight Loss Drug Stocks to Buy According to Analysts. In this article, we are going to take a look at where Teva Pharmaceuticals Industries Limited  stands against other best weight loss drug stocks to buy according to analysts.Global Surge in Obesity Medication Market Driven by GLP-1 Drugs. Morgan Stanley Research has increased its prediction for the global market for obesity medications from $77 billion to $105 billion by 2030 in light of this demand increase. In 2023, brand-name obesity drugs brought in almost $6 billion.Challenges and Accessibility Issues in the GLP-1 Weight Loss Medication Market. The latest generation of GLP-1 medications are being hailed by some as “miracle drugs” that can cure obesity. However, not all obese persons can utilize GLP-1s due to the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/teva-pharmaceuticals-industries-limited-teva-195223885.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1363072403.SGD","BK4566","LU0912757837.SGD","LU1989772923.USD","BK4584","LU1162221912.USD","LU0098860793.USD","BK4588","LU1989772840.SGD","BK4581","BK4007","LU1074936037.SGD","LU0006306889.USD","LU0795875086.SGD","BK4557","LU0158827781.USD","LU0158827948.USD","LU1732800096.USD","LU1548497426.USD","LU0320765646.SGD","LU1732799900.SGD","LU1720051108.HKD","BK4559","LU0106261372.USD","LU2271345857.HKD","LU0267386448.USD","BK4596","BK4127","LU0106831901.USD","BK4585","LU2089283258.USD","LU2023251221.USD","LU1668664300.SGD","LU2347655156.SGD","IE00BKVL7J92.USD","LU0795875169.SGD","BK4534","LU1720051017.SGD","LU2028103732.USD","LU0225283273.USD","LU0314104364.USD","LU2357305700.SGD","BK4504","TEVA","LU0971096721.USD","LU2133065610.SGD","BK4516","IE00BZ1G4Q59.USD","LU2089284900.SGD","LU2111349929.HKD"],"gpt_icon":0},{"id":"2516143567","title":"Sanofi's Positive Duvakitug Data Raises Market Questions for Teva Pharmaceutical Industries (NYSE:TEVA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2516143567","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516143567?lang=en_us&edition=fundamental","pubTime":"2025-03-02 01:16","pubTimestamp":1740849372,"startTime":"0","endTime":"0","summary":"Teva Pharmaceutical Industries (NYSE:TEVA) saw its share price decrease by 1.67% over the past week. This decline coincided with the acceptance of the supplemental New Drug Application for UZEDY, an extended-release injectable suspension for bipolar I disorder. While this was a positive regulatory update, the broader market context showed a drop of 1.4% over the same period, driven by challenges like tariff concerns and a mixed performance among tech stocks. Despite rising at the end of the...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/308047-main-header/1585187365850","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/308047-main-header/1585187365850"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-teva/teva-pharmaceutical-industries/news/sanofis-positive-duvakitug-data-raises-market-questions-for","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SNYNF","BK4007","BK4585","NYSE","BK4566","BK4584","BK4588","TEVA","BK4557","BK4559","BK4596"],"gpt_icon":0},{"id":"2514831388","title":"Is Teva Pharmaceutical Industries Limited (TEVA) the Best Low Price Pharma Stock to Invest In Right Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2514831388","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514831388?lang=en_us&edition=fundamental","pubTime":"2025-02-27 21:34","pubTimestamp":1740663253,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the 12 Best Low Price Pharma Stocks To Invest In Right Now.In this article, we are going to take a look at where Teva Pharmaceutical Industries Limited  stands against the other pharma stocks.The Rising Demand for Weight-Loss Medications and GLP-1 Developments. Competition with the leading companies in the anti-obesity business, which is expected to grow to $130 billion by 2030, is no longer the main emphasis. The possibility for additional participants to enter the field is growing along with the possible applications of GLP-1s. For example, the Swiss business Roche entered the weight-loss drug sweepstakes last year when it paid up to $3.1 billion to acquire California-based Carmot Therapeutics. The corporation wants to \"fast-track\" its anti-obesity medicines to regain faith in its pipeline a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/teva-pharmaceutical-industries-limited-teva-133413831.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4543","BK4609","IE00BMPRXN33.USD","BK4588","BK4566","BK4559","IE00BMPRXQ63.HKD","IE00BMPRXR70.SGD","BK4141","BK4584","BK4585","BK4596","BK4159","CAGR","LU0348723411.USD","BK4007","TEVA","BK4557"],"gpt_icon":1},{"id":"2514801014","title":"2025 Community Routes: Access to Mental Health Care Grants Awarded to Clinics in Alabama, Mississippi, and Texas, Funded by Teva Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2514801014","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514801014?lang=en_us&edition=fundamental","pubTime":"2025-02-27 21:00","pubTimestamp":1740661203,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250227:nTUA7H5CZ7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4557","BK4585","BK4588","BK4007","BK4566","BK4559","BK4584","BK4596","TEVA"],"gpt_icon":0},{"id":"2514046938","title":"2025 Community Routes: Access to Mental Health Care Grants Awarded to Clinics in Alabama, Mississippi, and Texas, Funded by Teva Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2514046938","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514046938?lang=en_us&edition=fundamental","pubTime":"2025-02-27 21:00","pubTimestamp":1740661200,"startTime":"0","endTime":"0","summary":"The $2 million in new funding is part of a $4 million commitment from Teva, launched in 2022, to expand access to critical mental health services across 10 statesSANTA BARBARA, Calif. and PARSIPPANY, ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/27/3033773/0/en/2025-Community-Routes-Access-to-Mental-Health-Care-Grants-Awarded-to-Clinics-in-Alabama-Mississippi-and-Texas-Funded-by-Teva-Pharmaceuticals.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4596","BK4588","BK4584","BK4566","BK4559","BK4007","BK4557","BK4585","TEVA"],"gpt_icon":0},{"id":"2514980576","title":"Analysts Are Bullish on These Healthcare Stocks: Sarepta Therapeutics (SRPT), MannKind (MNKD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2514980576","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514980576?lang=en_us&edition=fundamental","pubTime":"2025-02-27 20:10","pubTimestamp":1740658254,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Sarepta Therapeutics (SRPT – Research Report), MannK...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-sarepta-therapeutics-srpt-mannkind-mnkd?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-sarepta-therapeutics-srpt-mannkind-mnkd?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BFTCPJ56.SGD","HCSG","BK4584","IE00BJJMRZ35.SGD","BK4585","BK4139","MNKD","BK4137","IE00BJT1NW94.SGD","IE00B2B36J28.USD","IE0002141913.USD","IE0009355771.USD","SRPT"],"gpt_icon":0},{"id":"2514459938","title":"MannKind Corporation Reports Strong 2024 Financial Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2514459938","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514459938?lang=en_us&edition=fundamental","pubTime":"2025-02-27 12:35","pubTimestamp":1740630946,"startTime":"0","endTime":"0","summary":"MannKind Corporation ( ($MNKD) ) has released its Q4 earnings. Here is a breakdown of the information MannKind Corporation presented to its investo...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mannkind-corporation-reports-strong-2024-financial-growth?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mannkind-corporation-reports-strong-2024-financial-growth?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MNKD","BK4139","BK4584"],"gpt_icon":0},{"id":"2514989117","title":"BRIEF-MannKind Files For Mixed Shelf - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2514989117","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514989117?lang=en_us&edition=fundamental","pubTime":"2025-02-27 07:12","pubTimestamp":1740611529,"startTime":"0","endTime":"0","summary":"BRIEF-MannKind Files For Mixed Shelf - SEC FilingFeb 26  - MannKind Corp MNKD.O:MANNKIND CORP FILES FOR MIXED SHELF - SEC FILINGMANNKIND : SALES AGREEMENT PROSPECTUS COVERS OFFERING OF UP TO $200 MILLION OF COMMON STOCK THAT MAY BE ISSUED FROM TIME TO TIMESource text: [ID:n0001193125-25-036840]Further company coverage: MNKD.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250226:nFWN3PH1SO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4584","BK4139","MNKD"],"gpt_icon":0},{"id":"2514409895","title":"MannKind files automatic mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2514409895","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514409895?lang=en_us&edition=fundamental","pubTime":"2025-02-27 05:55","pubTimestamp":1740606931,"startTime":"0","endTime":"0","summary":"16:52 EST MannKind (MNKD) files automatic mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving break...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mannkind-files-automatic-mixed-securities-shelf?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mannkind-files-automatic-mixed-securities-shelf?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4584","BK4139","MNKD"],"gpt_icon":0},{"id":"2514893787","title":"MannKind Corp Files for Mixed Shelf - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2514893787","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514893787?lang=en_us&edition=fundamental","pubTime":"2025-02-27 05:51","pubTimestamp":1740606689,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250226:nFWN3PH1SO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4584","BK4139","MNKD"],"gpt_icon":0}],"pageSize":16,"totalPage":2,"pageCount":1,"totalSize":31}]}}